N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Mutations in the NGLY1 (N-glycanase 1) gene, encoding an evolutionarily conserved deglycosylation enzyme, are associated with a rare congenital disorder leading to global developmental delay and neurological abnormalities. The molecular mechanism of the NGLY1 disease and its function in tissue and immune homeostasis remain unknown. Here, we find that NGLY1-deficient human and mouse cells chronically activate cytosolic nucleic acid–sensing pathways, leading to elevated interferon gene signature. We also find that cellular clearance of damaged mitochondria by mitophagy is impaired in the absence of NGLY1, resulting in severely fragmented mitochondria and activation of cGAS–STING as well as MDA5–MAVS pathways. Furthermore, we show that NGLY1 regulates mitochondrial homeostasis through transcriptional factor NRF1. Remarkably, pharmacological activation of a homologous but nonglycosylated transcriptional factor NRF2 restores mitochondrial homeostasis and suppresses immune gene activation in NGLY1-deficient cells. Together, our findings reveal novel functions of the NGLY1–NRF1 pathway in mitochondrial homeostasis and inflammation and uncover an unexpected therapeutic strategy using pharmacological activators of NRF2 for treating mitochondrial and immune dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Microglia-dependent synapse loss in type I interferon-mediated lupus
Bialas, A. R., Presumey, J., Das, A., van der Poel, C. E., Lapchak, P. H., Mesin, L., Victora, G., Tsokos, G. C., Mawrin, C., Herbst, R., et al. (2017) · Nature · doi:10.1038/nature22821 · Cited by 197 · cited 1×
“Increased IFN signaling in SLE is also recently reported to drive synapse loss of neurons, providing an explanation for the neurological symptoms observed in some SLE patients (Bialas et al., 2017).”
ResultRetractedImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 1×
“Nrf1 resides on the ER and requires deglycosylation and cleavage for activation, while Nrf2 resides in the cytosol and does not required NGLY1-mediated deglycosylation to become active (Kensler et al., 2007).”
BackgroundKarikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · cited 1×
“In fact, a previous study demonstrated that mtRNA is the most potent immunostimulatory mammalian RNA type (Karikó et al., 2005).”
BackgroundChen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 1×
“Mitochondrial morphology was categorized and enumerated as reported (Chen et al., 2003).”
BackgroundMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280 · cited 1×
“, 2015), or deficiency in cytosolic nucleic acid metabolizing enzymes, such as TREX1 (Stetson et al., 2008; Wolf et al., 2016), and cause a broad range of autoimmune and inflammatory diseases, including AGS and systemic lupus erythematosus (SLE; Yan, 2017).”
BackgroundApoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983 · cited 3×
“The ability of mtDNA to activate the cGAS–STI NG DNA-sensing pathway has been largely confined to acute external stimulations so far such as inhibition of caspases (White et al., 2014) and Dengue virus infection (Aguirre et al.”
BackgroundMethodAicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 3×
“Unchecked hyperactivation of type I IFN signaling has been described in several monogenic autoimmune and autoinflammatory diseases that are collectively known as type I interferonopathies (Crow and Manel, 2015).”
BackgroundInfluentialApoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Rongvaux, A., Jackson, R., Harman, C. C. D., Li, T., West, A. P., de Zoete, M. R., Wu, Y., Yordy, B., Lakhani, S. A., Kuan, C.-Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.037 · Cited by 847
Härtlova, A., Erttmann, S. F., Raffi, F. A., Schmalz, A. M., Resch, U., Anugula, S., Lienenklaus, S., Nilsson, L. M., Kröger, A., Nilsson, J. A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.012 · Cited by 716 · cited 2×
“, 2015), DNA damage (Härtlova et al., 2015), or deficiency in cytosolic nucleic acid metabolizing enzymes, such as TREX1 (Stetson et al.”
BackgroundRadhakrishnan, S. K., Lee, C. S., Young, P., Beskow, A., Chan, J. Y., & Deshaies, R. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.029 · Cited by 526 · cited 1×
“Nrf1 plays an important role in the proteasome “bounce-back” mechanism where it drives expression of proteasome subunit genes in response to proteotoxic stress (Radhakrishnan et al., 2010).”
BackgroundNew insights into the role of mitochondria in aging: mitochondrial dynamics and more
Seo, A. Y., Joseph, A.-M., Dutta, D., Hwang, J. C. Y., Aris, J. P., & Leeuwenburgh, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.070490 · Cited by 522 · cited 1×
“NGLY1 deficiency impairs mitophagy The mitochondrion is a dynamic organelle, and fragmented mitochondria can be caused by defects in either mitochondrial fusion or mitophagy, the latter of which is required for clearance of damaged mitochondria (Fig. 4 A; Seo et al., 2010).”
BackgroundGall, A., Treuting, P., Elkon, K. B., Loo, Y.-M., Gale, M., Barber, G. N., & Stetson, D. B. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.018 · Cited by 510 · cited 1×
“For example, Trex1−/− mice develop systemic autoinflammation due to the cGAS–STI NG pathway activation with an average survival of 2–3 mo; Sting−/− fully rescues the overall survival (Gall et al., 2012; Ahn et al., 2014).”
BackgroundRodero, M. P., & Crow, Y. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20161596 · Cited by 433
Fanconi Anemia Proteins Function in Mitophagy and Immunity
Sumpter, R., Sirasanagandla, S., Fernández, Á. F., Wei, Y., Dong, X., Franco, L., Zou, Z., Marchal, C., Lee, M. Y., Clapp, D. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.006 · Cited by 250 · cited 1×
“HeLa cells stably expressing Parkin (HeLa/Parkin) was generated and maintained as described previously (Sumpter et al., 2016).”
MethodPokatayev, V., Hasin, N., Chon, H., Cerritelli, S. M., Sakhuja, K., Ward, J. M., Morris, H. D., Yan, N., & Crouch, R. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151464 · Cited by 245
Self-citation
Cited by
The type I interferonopathies: 10 years on
Crow, Y. J., & Stetson, D. B. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00633-9 · Cited by 489
Tonic prime-boost of STING signalling mediates Niemann–Pick disease type C
Chu, T.-T., Tu, X., Yang, K., Wu, J., Repa, J. J., & Yan, N. (2021) · Nature · doi:10.1038/s41586-021-03762-2 · Cited by 240
Self-citationKröll‐Hermi, A., Ebstein, F., Stoetzel, C., Geoffroy, V., Schaefer, E., Scheidecker, S., Bär, S., Takamiya, M., Kawakami, K., Zieba, B. A., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911861 · Cited by 65
“Because target genes of TCF11/Nrf1 include anti-inflammatory factors (Yang et al., 2018; Widenmaier et al., 2017), it is also conceivable that inflammation might play a role in this process.”
Ebstein, F., Küry, S., Most, V., Rosenfelt, C., Scott-Boyer, M.-P., van Woerden, G. M., Besnard, T., Papendorf, J. J., Studencka-Turski, M., Wang, T., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3189 · Cited by 36
“This observation supports the growing consensus that mitochondrial dysfunction is a key determinant of the pathogenesis of neurodevelopment (89) and the cause of interferonopathies (90).”
BackgroundMiao, X., Wu, J., Chen, H., & Lu, G. (2022) · Nutrients · doi:10.3390/nu14091690 · Cited by 13
Metadata
- Authors
- Yang, K., Huang, R., Fujihira, H., Suzuki, T., & Yan, N.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-08-22
- Volume
- 215
- Issue
- 10
- Pages
- 2600-2616
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2888480058
- Cited by
- 121
- References
- 17
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.